Maagda, Cheryl .

HRN: 24-89-02  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/23/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/23/2024
04/29/2024
IV
4.5gm
Q8
Septicemia
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: